Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
HEPAHepion Pharmaceuticals, Inc.
| Figure | HEPAHepion Pharmaceuticals, Inc.FY2023 · Dec |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | — |
| Net income | $8.28M |
| Net income, yoy | +37.3% |
| Net margin | — |
| Free cash flow | $40.90M |
| FCF margin | — |
| EPS, diluted | $0.88 |
Add another company.
Annual · FY2020–FY2023 · USD
From SEC EDGARSame fiscal periods, as filed